Weekly Recap | Beigene +9.89%, earnings beat and guidance raisedWeekly Review·Nov 7, 2026 at 08:36 AMONC+1.60%
Weekly Recap | Beigene +2.32%, Tevimbra combination survival data landsWeekly Review·Oct 24, 2026 at 06:49 AMONC+1.60%
Weekly Recap | Beigene +4.12%, consensus target above spotWeekly Review·Oct 17, 2026 at 07:51 AMONC+1.60%
Weekly Recap | Beigene -1.01%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 07:17 AMONC+1.60%
Weekly Recap | Beigene -0.77%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:24 AMONC+1.60%
Weekly Recap | Beigene +2.85%, consensus target 20% above spotWeekly Review·Sep 26, 2026 at 06:50 AMONC+1.60%
Weekly Recap | Beigene -2.31%, consensus target about 20% above spotWeekly Review·Sep 5, 2026 at 07:45 AMONC+1.60%
